Acro Biomedical Co (Acro Biomedical Co) Total Stockholders Equity : $0.34 Mil (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Total Stockholders Equity?

Acro Biomedical Co's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $0.34 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Acro Biomedical Co's Book Value per Share for the quarter that ended in Jun. 2023 was $0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Acro Biomedical Co's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.04.

Acro Biomedical Co Total Stockholders Equity Historical Data

The historical data trend for Acro Biomedical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Total Stockholders Equity Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

1.24

0.87

0.69

0.64

0.49

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															0.58	0.49	0.49	0.41	0.34

Acro Biomedical Co (OTCPK:ACBM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Acro Biomedical Co's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.34	-	0)	/	60.042
	=	0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Acro Biomedical Co's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.013	+	0)	/	0.34
	=	0.04

Acro Biomedical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu

director, 10 percent owner, officer: CEO

2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines